Dementia

Making dementia preventable and treatable

Florey researchers are recognised as world leaders in dementia research – from defining the natural history of the disease and its pathology, to taking drugs from the laboratory to clinical trials. Future research in dementia at The Florey will build upon its strong track record to identify new drug targets, improve patient diagnosis, trial new treatments and advance care.

The challenge

 

Mission leads

Headshot_Scott Ayton

Professor Scott Ayton

Group Head
Research Lead

Professor Christopher Rowe researcher profile

Professor Christopher Rowe

Clinical Lead
Clinical Lead

Professor Trevor Kilpatrick

Professor Trevor Kilpatrick

Director and Group Head
Executive Lead

Latest news in dementia

Source information

  • Australian Institute of Health and Welfare (2022) Dementia in Australia, AIHW, Australian Government, accessed 20 January 2023.
  • Australian Institute of Health and Welfare (2022) Dementia in Australia, AIHW, Australian Government, accessed 20 January 2023.
  • Based on Dementia Australia’s analysis of the following publications: M.Kostas et al., 2016 National Aged Care Workforce Census and Survey – The Aged Care Workforce, 2016, Department of Health, 2017, p. xv, NATSEM, Dementia Prevalence in Australia, Dementia Australia, 2018, Alzheimer’s Disease International and Jarolinska Institutet, Global estimates of informal care, Alzheimer’s Disease International, 2018, p. 8., Access Economics (2010) Caring Places.
  • Australian Institute of Health and Welfare (2022) Dementia in Australia, AIHW, Australian Government, accessed 20 January 2023.